Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

August 1, 2026

Conditions
IBDRheumatoid Arthritis
Interventions
DRUG

Adalimumab-800CW

Intravenous administration of 4.5 mg, 15 mg or 25 mg 2 - 4 days prior to the fluorescence imaging

DEVICE

Fluorescence Imaging

"Rheumatoid arthritis: a flexible fiber-bundle is attached to a fluorescence camera platform to enable the detection of fluorescence signals open-air by using a black-box.~Inflammatory bowel disease: a flexible fiber-bundle is attached to a fluorescence camera platform to enable the detection of fluorescence signals. The fluorescence fibre-probe is inserted through the standard working channel of the standard clinical endoscope. Fluorescence imaging will be performed during standard clinical colonoscopy."

Trial Locations (1)

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

University Medical Center Groningen

OTHER